Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Defaye

Showing results (181-190 of 264) with videos related to

Pageof 27
Sort By:
Heart Rhythm|March 15, 2025
Dual-chamber leadless pacemaker implant procedural outcomes: Insights from the AVEIR DR i2i studyRahul N Doshi, James E Ip, Pascal Defaye, et al.
ESC Heart Failure|January 18, 2024
Pre-emptive treatment of heart failure exacerbations in patients managed with the HeartLogic™ algorithmRodrigue Garcia, Daniel Gras, Jacques Mansourati, et al.
Circulation. Arrhythmia and Electrophysiology|March 27, 2025
One-Year Safety and Performance of a Dual-Chamber Leadless PacemakerReinoud E Knops, James E Ip, Rahul Doshi, et al.
Journal of Electrocardiology|October 4, 2020
Prognostic significance of a low T/R ratio in Brugada syndromeAntoine Delinière, Adrian Baranchuk, Francis Bessière, et al.
Heart Rhythm|April 16, 2017
The QUIDAM study: Hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic riskAntoine Andorin, Jean-Baptiste Gourraud, Jacques Mansourati, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 21, 2019
Prophylactic implantable cardioverter-defibrillator in the very elderlyCyril Zakine, Rodrigue Garcia, Kumar Narayanan, et al.
The American Journal of Cardiology|January 25, 2020
Impact of Type-2 Diabetes Mellitus on the Outcomes of Catheter Ablation of Atrial Fibrillation (European Observational Multicentre Study)Antonio Creta, Rui Providência, Pedro Adragão, et al.
Archives of Cardiovascular Diseases|September 1, 2019
Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death in the real world: Main findings from the French multicentre DAI-PP programme (pilot phase)Serge Boveda, Rodrigue Garcia, Pascal Defaye, et al.
The American Journal of Cardiology|August 27, 2016
Outcome of Primary Prevention Implantable Cardioverter Defibrillator Therapy According to New York Heart Association Functional ClassificationRui Providência, Serge Boveda, Pascal Defaye, et al.
Archives of Cardiovascular Diseases|November 29, 2011
Guidelines issued by the French Society of Cardiology concerning the competence, performance and environment required in the practice of diagnostic and interventional cardiac electrophysiologyOlivier Piot, Frédéric Anselme, Serge Bovéda, et al.
Pageof 27

Showing results (181-190 of 264) with videos related to

Sort By:
Pageof 27
Heart Rhythm|March 15, 2025
Dual-chamber leadless pacemaker implant procedural outcomes: Insights from the AVEIR DR i2i studyRahul N Doshi, James E Ip, Pascal Defaye, et al.
ESC Heart Failure|January 18, 2024
Pre-emptive treatment of heart failure exacerbations in patients managed with the HeartLogic™ algorithmRodrigue Garcia, Daniel Gras, Jacques Mansourati, et al.
Circulation. Arrhythmia and Electrophysiology|March 27, 2025
One-Year Safety and Performance of a Dual-Chamber Leadless PacemakerReinoud E Knops, James E Ip, Rahul Doshi, et al.
Journal of Electrocardiology|October 4, 2020
Prognostic significance of a low T/R ratio in Brugada syndromeAntoine Delinière, Adrian Baranchuk, Francis Bessière, et al.
Heart Rhythm|April 16, 2017
The QUIDAM study: Hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic riskAntoine Andorin, Jean-Baptiste Gourraud, Jacques Mansourati, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 21, 2019
Prophylactic implantable cardioverter-defibrillator in the very elderlyCyril Zakine, Rodrigue Garcia, Kumar Narayanan, et al.
The American Journal of Cardiology|January 25, 2020
Impact of Type-2 Diabetes Mellitus on the Outcomes of Catheter Ablation of Atrial Fibrillation (European Observational Multicentre Study)Antonio Creta, Rui Providência, Pedro Adragão, et al.
Archives of Cardiovascular Diseases|September 1, 2019
Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death in the real world: Main findings from the French multicentre DAI-PP programme (pilot phase)Serge Boveda, Rodrigue Garcia, Pascal Defaye, et al.
The American Journal of Cardiology|August 27, 2016
Outcome of Primary Prevention Implantable Cardioverter Defibrillator Therapy According to New York Heart Association Functional ClassificationRui Providência, Serge Boveda, Pascal Defaye, et al.
Archives of Cardiovascular Diseases|November 29, 2011
Guidelines issued by the French Society of Cardiology concerning the competence, performance and environment required in the practice of diagnostic and interventional cardiac electrophysiologyOlivier Piot, Frédéric Anselme, Serge Bovéda, et al.
Pageof 27